Please rotate your device to portrait mode


Join dr Gisele Deblandre's talk in Miami


Miami, USA

Come and join dr Gisele Deblandre's talk on Quality by Design at the Phacilitate Cell and Gene therapy world conference in Miami. You will learn about MaSTherCell's process development approach for T-cell based processes.

Full title:

Quality by Design approach for development and optimization of T cell-based processes. A focus on process analytics

She'll be up on Wednesday the 24th of January at 16:05. Visit the conference website here.

Cell and Gene Therapy World (Phacilitate)



Visit us at the Bioprocess Hub at Phacilitate Miami. Have a tour within our facility, we will welcome you with our VR experience.. The MaSTherCell team will also be at the booth BP6 to discuss your development and manufacturing needs. 

To join us at Phacilitate, use the code MSTH25 during registration to get 25% off. Register here.

Bioproduction vol7 Cell and Gene Therapies B4B-Connection


Charleroi, Belgium

Join our workshop in collaboration with Bone Therapeutics: “Challenges of industrialization and automation of cell therapy processes”. 

MaSTherCell Receives 5 million Equity Investment from SFPI


GOSSELIES, Nov. 21, 2017 -- MaSTherCell, a full service contract development and manufacturing organization (CDMO), wholly-owned subsidiary of Orgenesis Inc. (OTCQB:ORGS), today announces it has entered an agreement with Société Fédérale de Participations et d'Investissement (“SFPI”), pursuant to which SFPI is making an equity investment in MaSTherCell, Orgenesis’ wholly-owned Belgian-based subsidiary, in the aggregate amount of €5 million (approximately $5.9 million) for 16.67% of MaSTherCell.

More details here.

GMP Accreditation Renewal


Following the audit of our GMP activities by the FAMHP (Federal Agency for Medicines and Health Products), we are pleased to announce the successful completion of the audit with no critical deficiencies and no major deficiencies. Once again we have met the requirements and our GMP certificate is extended thanks to the hard work of the MaSTherCell’s team. We also received a favorable opinion to extend the authorization to the manufacturing of gene therapy products.

We think that quality must be done right through our best-in-class quality services but also daily in our quality-minded work and transparent communication.

The Process Diagnostic : How to optimize the technology transfer and the development


A critical aspect of cell therapy industrialization is process development. It is all about how to industrialize the cell therapy product within short time frames. MaSTherCell has developed a process diagnostic tool to help put together the development plan. Mathieu Anceau, Technology Transfer Supervisor at MaSTherCell, tell us more about it. He explains how creating a strong process diagnostic lays the foundations for a successful technology transfer and development towards a process fit for industrialization.

Click here to download the paper.